Hematopoietic Stem Cell Transplantation Market is expected to garner a value of US$ 15 Billion

The global hematopoietic stem cell transplantation market had a market value of US$ 7 billion in 2023 and is expected to reach a market value of US$ 15 billion by 2033, growing at an 8% CAGR from 2023 to 2033. The global hematopoietic stem cell transplantation industry is expected to grow significantly over the forecast …

Filariasis Treatment Market is projected to exhibit a CAGR of 10.1% from 2023 to 2033

The global filariasis treatment market is expected to reach US$ 10.96 billion in 2023, growing at a CAGR of 10.1% between 2023 and 2033. Filariasis is more common in Africa and the developing world as a poor-disease people’s and a sign of underdevelopment. Because cities are growing uncontrollably and mosquito breeding grounds are plentiful, the …

Head and Neck Cancer (HNC) Therapeutics Market is expected to surpass US$ 5.19 Billion in 2033

The global Head and Neck Cancer (HNC) Therapeutics market is expected to exceed an impressive valuation of US$ 5.19 Billion by 2033, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Because they are less expensive and more precise to approach than surgeries, advances in the detection and treatment of head …

Quadriplegia Treatment Market is expected to flourish at a CAGR of 4.7%

In 2022, the Quadriplegia Treatment Market size is anticipated to be worth US$1,468.4 million. The global demand for quadriplegia therapy is anticipated to reach around US$ 2,324.4 Million by 2032, growing at a CAGR of 4.7% between 2022 and 2032. The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities …

Branded Generics Market is poised to expand at a CAGR of 5.8% during 2023to 2031

Future Market Insights (FMI), an ESOMAR-certified market research firm, forecasts that the Branded Generics Market will grow by 4.9% year on year in 2021, reaching a valuation of 283.2 Billion. Because of their increasing popularity, the Branded Generics Market is expected to grow at a CAGR of 5.8% between 2021 and 2031. In 2021, the …

Teledentistry Market is expected to reach US$ 6.56 Billion | FMI

The global teledentistry market is expected to reach a market value of US$ 1.45 billion in 2022 and a market value of US$ 6.56 billion by 2032, growing at a CAGR of 16.30% between 2022 and 2032. The growing need to reduce dental care costs, the widespread adoption of mHealth in dental practises, the internet …

Veterinary Electrosurgery Market is expected to accumulate USD 993.41 Million by 2032

The global veterinary electrosurgery market garnered a value of USD 471.96 Million in 2021 and is expected to secure USD 505 Million by 2022. The market is expected to accumulate USD 993.41 Million by 2032 while expanding at a CAGR of 7% during the forecast period from 2022 to 2032. Growth of the market can be attributed to rise …

Dual Balloon Angioplasty Catheter Market to expand at a 3.2% value CAGR by 2032

The global dual balloon angioplasty catheter market is projected to exhibit steady growth with a CAGR of 3.2% and a valuation touching US$ 199.8 Million in 2022 surpassing US$ 281.8 Million in 2032. The increasing prevalence of cardiovascular disorders is expected to contribute to growth in the market. During the historical forecast from 2016 to 2021, a …

Microfluidic Modulation Spectroscopy Market Insights on Emerging Scope Prophesy

Microfluidic modulation spectroscopy is an emerging technique of spectroscopy for analysing the secondary structure of the protein. The company named RedShift BioAnalytics launched a product named AQS3 which uses the patented technique of microfluidic modulation spectroscopy. This technique uses mid-infrared laser spectroscopy in microfluidics environment and uses advanced signal processing to measure the secondary structure …

Anemia Treatment Market Size to Reach US$ 14.9 Billion by 2028 | CAGR of 6.9% By FMI

The global Anemia therapy market is expected to exceed US$ 10.0 billion in 2022. The market is expected to be worth US$ 14.9 billion by 2028, with sales increasing at a robust 6.9% CAGR. Most of the demand for anemia treatment is driven by the condition as a result of one or more chronic diseases, according to a new research study by Future …